XBIT

2.84

0.00% 0.00

Handel nachbörslich: 2.84

Xbiotech Inc (XBIT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$2.84

Offen:

$2.85

24-Stunden-Volumen:

39,523

Relative Volume:

0.78

Marktkapitalisierung:

$86.59M

Einnahmen:

$4.01M

Nettoeinkommen (Verlust:

$-38.53M

KGV:

-2.254

EPS:

-1.26

Netto-Cashflow:

$-32.27M

1W Leistung:

-6.58%

1M Leistung:

-10.13%

6M Leistung:

-58.42%

1J Leistung:

-66.03%

1-Tages-Spanne:

$2.81

$2.955

1-Wochen-Bereich:

$2.81

$3.09

52-Wochen-Spanne:

$2.65

$8.6352

Xbiotech Inc Stock (XBIT) Company Profile

Firmenname

Xbiotech Inc

Sektor

Healthcare (1173)

Branche

Biotechnology (668)

Telefon

512-386-2900

Adresse

5217 WINNEBAGO LANE, AUSTIN, TX

Mitarbeiter

Twitter

@xbiotech_usa

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

XBIT's Discussions on Twitter

Vergleichen Sie XBIT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
XBIT Xbiotech Inc	2.84	90.85M	4.01M	-38.53M	-32.27M	-1.26
ONC Beigene Ltd Adr	241.43	24.41B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	436.00	111.55B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.335	42.47M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	588.34	63.16B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	75.06	5.92B	0	-153.72M	-103.81M	-2.00

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-06-14	Eingeleitet	Piper Jaffray	Overweight
2017-04-21	Herabstufung	Noble Financial	Buy → Hold
2016-06-28	Bestätigt	Noble Financial	Buy

Xbiotech Inc Aktie (XBIT) Neueste Nachrichten

May 20, 2025

XBiotech (NASDAQ:XBIT) Shares Cross Below 50 Day Moving AverageWhat's Next? - MarketBeat

May 20, 2025

May 16, 2025

Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation - Yahoo Finance

May 16, 2025

May 15, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 07, 2025

JPMorgan Chase & Co. Acquires 5,930 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

May 07, 2025

JPMorgan Chase & Co. Buys 2,250 Shares of Permian Basin Royalty Trust (NYSE:PBT) - Defense World

May 07, 2025

JPMorgan Chase & Co. Trims Stake in Clipper Realty Inc. (NYSE:CLPR) - Defense World

May 07, 2025

May 06, 2025

XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat

May 06, 2025

May 01, 2025

Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire

May 01, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat

Apr 27, 2025

Apr 22, 2025

Top Premarket Gainers - marketscreener.com

Apr 22, 2025

Apr 14, 2025

XBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat

Apr 14, 2025

Apr 13, 2025

XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World

Apr 13, 2025

Apr 05, 2025

XBiotech stock plunges to 52-week low at $2.91 amid market challenges - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat

Apr 04, 2025

Apr 01, 2025

XBiotech Announces Board Member Retirement - TipRanks

Apr 01, 2025

Mar 29, 2025

XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat

Mar 29, 2025

Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Mar 29, 2025

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire

Mar 29, 2025

Mar 23, 2025

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat

Mar 23, 2025

Mar 18, 2025